Literature DB >> 9399577

Downregulation of calpastatin in rat heart after brief ischemia and reperfusion.

Y Sorimachi1, K Harada, T C Saido, T Ono, S Kawashima, K Yoshida.   

Abstract

The activities of calpain and its endogenous inhibitor, calpastatin, were measured in the soluble fraction of perfused rat heart after ischemia for 5-20 min and reperfusion for up to 30 min. The method for m-calpain measurement was modified: washing of the DEAE-cellulose column with 0.18 M NaCl instead of 0.15 M NaCl increased the m-calpain activity 12.5-fold. Ischemia for 20 min followed by reperfusion for 30 min did not affect the m-calpain activity but decreased the calpastatin activity. m-Calpain was enriched in the nucleus-myofibril fraction but was not further translocated on ischemia-reperfusion. Mu-calpain was below the limit of detection on immunoblotting or casein zymography, but its mRNA was substantially expressed, as detected on Northern blotting. Casein zymography also revealed a novel Ca2+-dependent protease without the typical characteristics of mu- or m-calpain. The immunoblotting of myocardial fractions showed that calpastatin was proteolyzed on ischemia-reperfusion. The calpastatin proteolysis was suppressed by a calpain inhibitor, Ac-Leu-Leu-norleucinal. Calpastatin may sequester calpain from its substrates in the normal myocardium, but may be proteolyzed by calpain in the presence of an unidentified activator in the early phase of calpain activation during ischemia-reperfusion, resulting in the proteolysis of calpastatin and then other calpain substrates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399577     DOI: 10.1093/oxfordjournals.jbchem.a021818

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  21 in total

Review 1.  Tear me down: role of calpain in the development of cardiac ventricular hypertrophy.

Authors:  Cam Patterson; Andrea L Portbury; Jonathan C Schisler; Monte S Willis
Journal:  Circ Res       Date:  2011-08-05       Impact factor: 17.367

2.  In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium.

Authors:  Santhosh K Mani; Hirokazu Shiraishi; Sundaravadivel Balasubramanian; Kentaro Yamane; Meenakshi Chellaiah; George Cooper; Naren Banik; Michael R Zile; Dhandapani Kuppuswamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-16       Impact factor: 4.733

3.  Calpain, calpastatin activities and ratios during myocardial ischemia-reperfusion.

Authors:  D Enns; M Karmazyn; J Mair; A Lercher; J Kountchev; A Belcastro
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

4.  Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor.

Authors:  S Sandmann; M Yu; T Unger
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

5.  Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat.

Authors:  S Cuzzocrea; M C McDonald; E Mazzon; H Mota-Filipe; T Centorrino; M L Terranova; A Ciccolo; D Britti; A P Caputi; C Thiemermann
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

6.  KSHV reduces autophagy in THP-1 cells and in differentiating monocytes by decreasing CAST/calpastatin and ATG5 expression.

Authors:  R Santarelli; M Granato; G Pentassuglia; V Lacconi; M S Gilardini Montani; R Gonnella; M Tafani; M R Torrisi; A Faggioni; M Cirone
Journal:  Autophagy       Date:  2016-10-07       Impact factor: 16.016

7.  Maitotoxin induces calpain but not caspase-3 activation and necrotic cell death in primary septo-hippocampal cultures.

Authors:  X Zhao; B R Pike; J K Newcomb; K K Wang; R M Posmantur; R L Hayes
Journal:  Neurochem Res       Date:  1999-03       Impact factor: 3.996

Review 8.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

9.  Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia.

Authors:  Ming Sun; Chao Xu
Journal:  Cell Mol Neurobiol       Date:  2007-08-22       Impact factor: 5.046

Review 10.  Energetic depression caused by mitochondrial dysfunction.

Authors:  Frank Norbert Gellerich; Sonata Trumbeckaite; Tobias Müller; Marcus Deschauer; Ying Chen; Zemfira Gizatullina; Stephan Zierz
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.